P. Morel

Commissariat à l'Énergie Atomique et aux Énergies Alternatives — France

Physics and Astronomy · Physical Sciences

39h-index8.1kcitations378works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Stellar, planetary, and galactic studies(87), Magnetic confinement fusion research(61), Solar and Space Plasma Dynamics(54), Astronomy and Astrophysical Research(52), Astro and Planetary Science(46)

Publications374 total

Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy
Seminars in Hematology·2025· 4 cited
Supplementary Data from A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation
2025Open Access
Supplementary Table S16 from A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation
2025Open Access
Nuclear data measurements with a Solid COunter for NEutrons (SCONE)
Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment·2025
Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLG
Blood·2024· 3 cited
Annuaire français de relations internationales
Éditions Panthéon-Assas eBooks·2023
Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease
Leukemia Research·2022· 13 cited
Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim
Blood·2022Open Access
A Phase 2 Single-Arm Study to Evaluate the Efficacy of Isatuximab, Pomalidomide and Low-Dose Dexamethasone, in Patients with AL Amyloidosis Not in VGPR or Better after Any Previous Therapy (IsAMYP)
Blood·2022
P-169: Bendamustine rituximab primary therapy for Waldenström Macroglobulinemia: an international, multicenter collaborative study
Clinical Lymphoma Myeloma & Leukemia·2022
Annuaire français de relations internationales
Éditions Panthéon-Assas eBooks·2022
Phase and amplitude evolution in the network of triadic interactions of the Hasegawa–Wakatani system
Physics of Plasmas·2022· 5 citedOpen Access
Phase and amplitude evolution in the network of triadic interactions of the Hasegawa-Wakatani system
arXiv (Cornell University)·2022Open Access
Author response for "Does early disease progression predict survival after first line-treatment of Waldenstrom macroglobulinemia"
2022
A differential approximation model for passive scalar turbulence
Journal of Physics A Mathematical and Theoretical·2021Open Access
Gyrokinetic investigation of Alfvén instabilities in the presence of turbulence
Plasma Physics and Controlled Fusion·2021Open Access
Un avenir pour l’Irak ?
Esprit·2021
A future for Iraq
Esprit·2021
Un futuro para Irak
Esprit·2021
Gyrokinetic investigation of the nonlinear interaction of Alfvénic modes and turbulence
MPG.PuRe (Max Planck Society)·2021
page 1 of 19Next →

Frequent Co-authors

P. Kervella(9), G. Berthomieu(6), J. Provost(6), Bruno Pichon(6), F. Thévenin(6), T. Görler(5), Y. Lebreton(4), S. Turck‐Chièze(4), Philip W. Anderson(3), J. P. Marques(3), M. J. Goupil(3), E. Di Folco(3), Thierry Jéron(3), Y. Sarazin(3), X. Garbet(3), P. Hennequin(3), T. Guillot(3), A. Bañón Navarro(3), M. Albrecht‐Marc(3), Daniele Carati(3)